Orica – Algo Buy
Orica is under Algo Engine buy conditions.

Orica is under Algo Engine buy conditions.

Ampol is under Algo Engine buy conditions.

ORG:SX is under Algo Engine buy conditions and has now been added to our model portfolio.
The strong cash flows from APLNG will offset the lower expected earnings in energy markets.

22/12 Update: ORG has now rallied over 10%

ETFS Fang+ is under Algo Engine buy conditions with support at $17.20

Cochlear is now under Algo Engine buy conditions and has been added to our ASX 100 model portfolio.
We expect 10% EPS growth over the next 12 months. Although, the stock remains expensive at 40x earnings and trading on a 1.8% yield.

Since writing the above post in Dec last year, COH has rallied from $175 to a high of $257. The subsequent pullback has seen buying interest rebuild at the higher low of $210.
This is the second cluster of Algo Engine buy signals and we’ve taken the opportunity to add to our original allocation.

16/12 Update: COH remains a buy at $215.

CSL has lobbed a US$11.7bn all cash public tender offer for Switzerland based specialty drug company Vifor Pharma.
The acquisition is being funded via a combination of a private placement, SPP and cash/debt, with commencement around 18 Jan-22.

Woolworths Group announced a disappointing trading update which revealed COVID had weighed heavily on earnings during the first half. The retailer anticipates $215mil in COVID-related expenses and before tax profit to fall from $1.3bn to $1.2bn.
We see value in the stock within the highlighted price range.

is under Algo Engine buy conditions and we see buying interest building above the $4.20 support level.
1Q22 Update and Reconfirming Guidance:
FY22 estimated FFO per security forecast in the range of 34.6 to 35.6 cents. Distribution per security is forecast to be within our target payout ratio of 75% to 85% of FFO.
Current market conditions remain uncertain and challenging with ongoing lockdowns and community transmission of COVID-19. All forward looking statements including FY22 earnings guidance are provided on the basis that the vaccination roll out continues and COVID-19 restrictions ease towards the end of CY21 and are underpinned by the following business assumptions:
• Residential settlement around 6,400 lots
• Residential operating profit margin ~18%
• Land Lease communities delivering ~300 sites in FY22
• Retail rent collection returning to levels experienced prior to recent lockdowns towards the end of CY21

SPDR S&P/ASX 200 Listed Property in under Algo Engine buy conditions since February at $11.30 and In July we’ve seen a further buy signal at $12.50.
SLF provides a basket trade with diversification across the REIT sector. SLF and GMG remain our preferred property allocations.

13/12 Update: The SLF continues to push higher and the ETF is now up 31% since being added to the All ETF model portfolio.

Or start a free thirty day trial for our full service, which includes our ASX Research.